US FDA slaps Glaxo with warning letter for FluLaval plant

June 25, 2014 10:45 AM

12 0

US FDA slaps Glaxo with warning letter for FluLaval plant

GlaxoSmithKline PLC was ordered by the U.S. Food and Drug Administration (FDA) to review its global manufacturing operations after its Canadian subsidiary was found to have violated quality requirements during the production of its flu vaccine FluLaval, according to a report by British newspaper The Guardian posted on its website on Wednesday.

The allegations, contained in a Warning Letter released by FDA on 24 June 2014, stem from a 31 March-9 April 2014 inspection of ID Biomedical Corporation’s—a GSK subsidiary since 2005—Quebec facility.

Read more

To category page

Loading...